NDC 80425-0363-01 - RABEPRAZOLE SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0363
- Requested NDC
- 80425-0363-01
- Package NDCs from labels
- 80425-0363-1, 80425-0363-2, 80425-0363-3, 80425-0363-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RABEPRAZOLE SODIUM - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0363-1 | RABEPRAZOLE SODIUM | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | 2 | |
| 80425-0363-2 | RABEPRAZOLE SODIUM | 60 in 1 BOTTLE | TABLET, DELAYED RELEASE | 60 | 2 | |
| 80425-0363-3 | RABEPRAZOLE SODIUM | 90 in 1 BOTTLE | TABLET, DELAYED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0363 | RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [ADVANCED RX OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250101_0863f340-4c7e-379a-e063-6394a90a758d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0363-1 | EA - Each | 80425-0363 | 144fd34a-43fb-427c-8f8b-46bfe2b77fea | 1 | 2023-12-05 |
| 80425-0363-2 | EA - Each | 80425-0363 | dee3dc6c-a69c-4eeb-bdc4-d6960bef4989 | 1 | 2023-12-05 |
| 80425-0363-3 | EA - Each | 80425-0363 | e3cfcd29-0d85-4fd1-8476-33a4271a6d0b | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 17C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb338c7-e99c-887d-e063-6394a90a977c | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 22N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb415b3-b1ba-42b8-e063-6394a90a90d7 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb42062-f298-5186-e063-6294a90ab043 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb44e1b-b24b-6c83-e063-6394a90a4b52 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb468db-3c38-922d-e063-6294a90adef8 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4b8ca-eced-b7ff-e063-6394a90aaefe | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 25W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb50784-444e-3bf3-e063-6294a90aa618 | 2026-10-25 | Warnings | 15FIX9V2JP |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-10-23 | Boxed warning, Adverse reactions | 3A3U0GI71G |
| Folivex | MULTIVITAMIN | Oncora Pharma, LLC | 98b4a821-c139-4e9b-99c7-6451af6c27ce | 2026-10-22 | Warnings, Adverse reactions | 3A3U0GI71G |
| KARYNG Complete SPF Sunscreen Medium/Dark | SUNSCREEN | Karyng LLC | 335eee1e-ef1c-41da-e063-6294a90ac273 | 2026-10-20 | Warnings | 15FIX9V2JP |
| KARYNG Complete SPF Sunscreen Light/Medium | SUNSCREEN | Karyng LLC | 33596253-413d-fba3-e063-6394a90a39e4 | 2026-10-19 | Warnings | 15FIX9V2JP |
| ALEX MD PHD Sheer Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | PHYSICIAN LABORATORIES INC | 8f64c4fa-92ee-4af0-ab1b-6c3673f9a622 | 2026-10-16 | Warnings | 15FIX9V2JP |
| ALEX MD PHD Tinted Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | PHYSICIAN LABORATORIES INC | 93873c34-5c72-43c8-b6c2-c65b596191d7 | 2026-10-16 | Warnings | 15FIX9V2JP |
| Solar Defense Non Tinted | TITANIUM DIOXIDE, ZINC OXIDE | HydroPeptide LLC | 45ec77c5-5ea1-0e51-e054-00144ff8d46c | 2026-10-14 | Warnings | 15FIX9V2JP |
| Solar Defense Tinted | TITANIUM DIOXIDE, ZINC OXIDE | HydroPeptide LLC | 45ec77c5-5ec4-0e51-e054-00144ff8d46c | 2026-10-14 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.